Site updated at Wednesday, 22 June 2016

Living with Dementia


Groups convince FDA to ease Alzheimer’s trial rules

Academic and industry experts said on Tuesday they have convinced U.S. regulators to ease safety restrictions imposed on clinical trials of Alzheimer’s drugs, a move that could improve the chances that a drug being developed jointly by Pfizer and Johnson & Johnson might succeed.

A 2008 study of 240 patients testing that drug, known… Groups convince FDA to ease Alzheimer’s trial rules   

Living with dementia

judgment1 - amyloid plaque4 - mediterranean diet1 - brain functions in patients1 - amyloid beta 42 peptide1 - bonfiglio1 - developing dementia2 - management of dementia1 - diabetes mellitus1 - parkinson's disease risk1 - dementia community1 - wernicke's-korsakoff syndrome10 - coronary artery1 - p-tau1 - cognitive function9 - apolipoprotein1 - phosphorylated alpha-synuclein1 - parkinson's sufferer1 - amyloid-targeting treatment1 - signs of alzheimer's1 - elderly people1 - stupidity2 - memory lapses2 - berrios and freeman1 - korsakoff's psychosis5 - delta-9-tetrahydrocannabinol1 - experimental alzheimer's drug1 - aging and dementia1 - professor lewy1 - postitron emission tomography1 -